These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6040883)

  • 1. [The future of drug patents].
    Berg AM; Lenstra JB; Voorhuis MH
    Pharm Weekbl; 1967 Feb; 102(6):106-9. PubMed ID: 6040883
    [No Abstract]   [Full Text] [Related]  

  • 2. [Discrimination against inventors?].
    Gremmée-Schaafsma J
    Pharm Weekbl; 1967 Jun; 102(26):626-33. PubMed ID: 5587164
    [No Abstract]   [Full Text] [Related]  

  • 3. The London Agreement and the future of parallel imports.
    Muir J
    Nat Biotechnol; 2008 Aug; 26(8):877-9. PubMed ID: 18688237
    [No Abstract]   [Full Text] [Related]  

  • 4. Patenting human genes in Europe -- past developments and prospects for the future.
    Straus J
    IIC Int Rev Ind Prop Copyr Law; 1995 Dec; 26(6):920-50. PubMed ID: 11660651
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharma patents in Europe: where are we going?
    Becker K
    Future Med Chem; 2009 May; 1(2):227-30. PubMed ID: 21425963
    [No Abstract]   [Full Text] [Related]  

  • 6. The use of generic or patent medicines in the Netherlands.
    Gebhardt DO
    J Med Ethics; 2005 Jul; 31(7):409. PubMed ID: 15994361
    [No Abstract]   [Full Text] [Related]  

  • 7. The people vs patents.
    New Sci; 2002 Jul; 175(2351):3. PubMed ID: 12625337
    [No Abstract]   [Full Text] [Related]  

  • 8. Biotech patenting slows in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
    [No Abstract]   [Full Text] [Related]  

  • 9. Allowing gene patents could be an expensive mistake for the US.
    Michel H
    Nature; 2000 Sep; 407(6802):285. PubMed ID: 11014161
    [No Abstract]   [Full Text] [Related]  

  • 10. Patents, but no cure.
    Schweiger T
    Splice Life; 1998; 4(5):12-3. PubMed ID: 11657659
    [No Abstract]   [Full Text] [Related]  

  • 11. German agencies sound alarm on risks of broad gene patents...as spending goes up for research.
    Schiermeier Q
    Nature; 2000 Jul; 406(6792):111. PubMed ID: 10910319
    [No Abstract]   [Full Text] [Related]  

  • 12. Alnylam dealt blow.
    Mullard A
    Nat Biotechnol; 2009 Mar; 27(3):213. PubMed ID: 19270653
    [No Abstract]   [Full Text] [Related]  

  • 13. Roche asked for more Taq patent evidence.
    Nature; 1995 Mar; 374(6518):108. PubMed ID: 7877674
    [No Abstract]   [Full Text] [Related]  

  • 14. Roche claims victory in bid for European Taq patent.
    Dickson D
    Nature; 1996 Nov; 384(6605):100. PubMed ID: 8906775
    [No Abstract]   [Full Text] [Related]  

  • 15. Roche fails to get European patent on Taq polymerase.
    Dickson D
    Nature; 1996 Jul; 382(6587):100. PubMed ID: 8700190
    [No Abstract]   [Full Text] [Related]  

  • 16. Implications of international drug approval systems on confidentiality of business secrets in the U.S. pharmaceutical industry.
    O'Reilly JT
    Food Drug Law J; 1998; 53(1):123-32. PubMed ID: 11795328
    [No Abstract]   [Full Text] [Related]  

  • 17. Europe backs trials on drugs for kids.
    Wild J
    Nature; 2005 Sep; 437(7057):304-5. PubMed ID: 16163313
    [No Abstract]   [Full Text] [Related]  

  • 18. Gene patents--a pharmaceutical perspective.
    Tribble JL
    Camb Q Healthc Ethics; 1998; 7(4):429-32. PubMed ID: 9752585
    [No Abstract]   [Full Text] [Related]  

  • 19. PCR. Roche dealt a setback on European Taq patent.
    Service RF
    Science; 2001 Jun; 292(5523):1815. PubMed ID: 11397920
    [No Abstract]   [Full Text] [Related]  

  • 20. Polymerase patent problems.
    Crowther SM; Burke JF; Thomas SM
    Nature; 1994 Nov; 372(6504):312. PubMed ID: 7832901
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.